| Symbol | Sector | Firm | Action | Grade | Target | Mkt Cap ▼ | Base | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NVDA | Technology | Needham | Reiterates | Buy | $270 | $5.4T | $223.47 | -0.5% | -1.8% | -1.9% | -0.2% | -1.1% | +0.8% |
| NVDA | Technology | Deutsche Bank | Reiterates | Hold | $255 | $5.2T | $223.47 | -0.5% | -1.8% | -1.9% | -0.2% | -1.1% | +0.8% |
| NVDA | Technology | Jefferies | Reiterates | Buy | $300 | $5.2T | $223.47 | -0.5% | -1.8% | -1.9% | -0.2% | -1.1% | +0.8% |
| NVDA | Technology | BofA Securities | Reiterates | Buy | $350 | $5.2T | $223.47 | -0.5% | -1.8% | -1.9% | -0.2% | -1.1% | +0.8% |
| NVDA | Technology | Evercore ISI | Reiterates | Outperform | $413 | $5.2T | $223.47 | -0.5% | -1.8% | -1.9% | -0.2% | -1.1% | +0.8% |
| NVDA | Technology | The Benchmark Company | Reiterates | Buy | $335 | $5.2T | $223.47 | -0.5% | -1.8% | -1.9% | -0.2% | -1.1% | +0.8% |
| NVDA | Technology | Robert W. Baird | Reiterates | Outperform | $500 | $5.2T | $223.47 | -0.5% | -1.8% | -1.9% | -0.2% | -1.1% | +0.8% |
| NVDA | Technology | KeyBanc Capital Markets | Reiterates | Overweight | $310 | $5.2T | $223.47 | -0.5% | -1.8% | -1.9% | -0.2% | -1.1% | +0.8% |
| NVDA | Technology | JP Morgan | Reiterates | Overweight | $280 | $5.2T | $223.47 | -0.5% | -1.8% | -1.9% | -0.2% | -1.1% | +0.8% |
| NVDA | Technology | Stifel | Reiterates | Buy | $282 | $5.2T | $223.47 | -0.5% | -1.8% | -1.9% | -0.2% | -1.1% | +0.8% |
| NVDA | Technology | UBS | Reiterates | Buy | $280 | $5.2T | $223.47 | -0.5% | -1.8% | -1.9% | -0.2% | -1.1% | +0.8% |
| NVDA | Technology | Goldman | Reiterates | Buy | $285 | $5.2T | $223.47 | -0.5% | -1.8% | -1.9% | -0.2% | -1.1% | +0.8% |
| NVDA | Technology | Morgan Stanley | Reiterates | Overweight | $288 | $5.2T | $223.47 | -0.5% | -1.8% | -1.9% | -0.2% | -1.1% | +0.8% |
| NVDA | Technology | Wedbush | Reiterates | Outperform | $330 | $5.2T | $223.47 | -0.5% | -1.8% | -1.9% | -0.2% | -1.1% | +0.8% |
| NVDA | Technology | RBC Capital Mkts | Reiterates | Outperform | $270 | $5.2T | $223.47 | -0.5% | -1.8% | -1.9% | -0.2% | -1.1% | +0.8% |
| TJX | Consumer Cyclical | Telsey Advisory Group | Reiterates | Outperform | $185 | $169.5B | $159.21 | +0.2% | -1.1% | +0.5% | +0.4% | -1.2% | -1.4% |
| LOW | Consumer Cyclical | Telsey Advisory Group | Reiterates | Outperform | $280 | $122.3B | $221.05 | -1.5% | -1.6% | -1.1% | -1.4% | +2.2% | +0.5% |
| INTU | Technology | BMO Capital Markets | Reiterates | Outperform | $412 | $113.1B | $383.93 | -18.7% | -20.0% | +4.2% | -4.9% | +1.1% | +1.7% |
| MDT | Healthcare | Goldman | Reiterates | Neutral | $84 | $101.4B | $78.15 | -0.8% | +0.0% | +0.6% | -1.3% | -2.1% | -0.5% |
| FDX | Industrials | Citigroup | Reiterates | Buy | $443 | $91.1B | $386.84 | +0.1% | +0.5% | +1.4% | +1.5% | +2.9% | -0.1% |